[1] 李晓明, 刘晨, 王健, 等. 肝细胞癌癌前病变富血供转化的风险分析[J]. 中华肝脏病杂志, 2020, 28(1):31-36. [2] 汤世雄, 黎丹, 肖恩华, 等. 基于3D分割技术的CT与磁共振增强检查对肝细胞癌体积评估的一致性分析[J]. 中国普通外科杂志, 2019, 28(7):871-877. [3] 胡纳, 杨国庆, 付泉水. CT和MRI在肝细胞癌微血管浸润中的诊断价值[J].中国临床医学影像杂志, 2018, 29(8):575-579. [4] 刘伟. 增强CT和MRI对射频消融治疗肝细胞肝癌的疗效评价[J]. 当代医学, 2017, 23(26):65-67. [5] Li J F, Li X Q, Weng J, et al. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma[J]. Medicine, 2018, 97(52):e13964. [6] 叶显俊, 胡蕾, 何年安, 等. Logistic回归模型评价常规超声及超声造影对胆管细胞癌与肝细胞癌的鉴别诊断价值[J]. 临床肝胆病杂志, 2019, 35(11):2502-2507. [7] English K, Brodin P, Zhu S, et al. Hepatocellular carcinoma treated with trans-arterial chemoembolization (TACE) versus TACE followed by ablative therapy:A retrospective outcome analysis of 281 unique lesions[J]. International Journal of Radiation Oncology Biology Physics, 2019, 105(1):E218-E219. [8] 罗超, 闵德庆, 胡达海, 等. 肝细胞癌介入治疗后经增强CT和MRI影像诊断的对比分析[J]. 临床和实验医学杂志, 2019, 18(20):2222-2224. [9] 张海涛. 多层螺旋CT平扫及三期动态增强扫描对肝细胞癌的诊断价值研究[J]. 中国CT和MRI杂志, 2018, 16(7):86-88. [10] Hatanaka K, Minami Y, Kudo M, et al. The gross classification of hepatocellular carcinoma:Usefulness of contrast-enhanced US[J]. Journal of Clinical Ultrasound, 2014, 42(1):1-8. [11] Fu R, Qiu T T, Ling W W, et al. Nodular focal fat sparing of liver mimicking hepatocellular carcinoma in contrast-enhanced ultrasound:A case report[J]. Medicine, 2019, 98(22):e15431. [12] 晏海平, 丁乃艳, 钱建兵. 64层螺旋CT三期增强扫描在小肝癌的诊断中的应用[J]. 现代医用影像学, 2020, 29(11):2016-2019. [13] Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma:Detection with double arterial phase multi-detector row helical CT[J]. Radiology, 2001, 218(3):763-767. [14] Rhee H, An C, Kim H Y, et al. Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement:More aggressive pathologic features[J]. Liver Cancer, 2019, 8(1):24-40. [15] Yang D, Li R, Zhang X H, et al. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound:Influence of the cellular differentiation, the tumor size and the underlying hepatic condition[J]. Scientific Reports, 2018, 8(1):4713-4714. [16] Zhang Y D, Zhu F P, Xu X, et al. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma:Comparison of liver imaging reporting and data system and criteria-free likert scale reporting models[J]. Journal of Magnetic Resonance Imaging, 2016, 43(2):373-383. [17] Lee J M, Yoon J H, Joo I, et al. Recent advances in CT and MR imaging for evaluation of hepatocellular carcinoma[J]. Liver Cancer, 2012, 1(1):22-40. [18] Bolog N, Andreisek G, Oancea I, et al. CT and MR imaging of hepatocellular carcinoma[J]. Journal of Gastrointestinal and Liver Diseases, 2011, 20(2):181-189. |